In-vitro inhibition by unsaturated fatty acids of the PPD- and PHA-induced lymphocyte response.
D000814:Aniline Compounds / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D001095:Arachidonic Acids / Q000494:pharmacology; D004586:Electrophoresis; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D005260:Female; D006801:Humans; D037102:Lectins / Q000494:pharmacology*; D008041:Linoleic Acids / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects*; D008264:Macrophages; D008297:Male; D009829:Oleic Acids / Q000494:pharmacology; D014373:Tuberculin / Q000037:antagonists & inhibitors* / Q000494:pharmacology
D000814:Aniline Compounds; D001095:Arachidonic Acids; D005231:Fatty Acids, Unsaturated; D037102:Lectins; D008041:Linoleic Acids; D009829:Oleic Acids; D014373:Tuberculin